These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 16140249

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
    Gandorfer A, Kampik A.
    Am J Ophthalmol; 2006 Apr; 141(4):784-5; author reply 785. PubMed ID: 16564844
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
    Wang LF, Ma JX, Liu JZ, Cai SZ, Lu LC, Wang ZD.
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
    [Abstract] [Full Text] [Related]

  • 5. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S, Lehti K, Keski-Oja J, Mignatti P.
    J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasmin treatment accelerates vascular endothelial growth factor clearance from rabbit eyes.
    Wu WC, Chen CC, Liu CH, Wang NK, Chen KJ, Chen TL, Hwang YS, Li LM, Lai CC.
    Invest Ophthalmol Vis Sci; 2011 Aug 03; 52(9):6162-7. PubMed ID: 21245395
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinases and their inhibitors in human vitreous.
    De La Paz MA, Itoh Y, Toth CA, Nagase H.
    Invest Ophthalmol Vis Sci; 1998 Jun 03; 39(7):1256-60. PubMed ID: 9620087
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit.
    Hikichi T, Kado M, Yoshida A.
    Retina; 2000 Jun 03; 20(2):195-8. PubMed ID: 10783954
    [Abstract] [Full Text] [Related]

  • 17. Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.
    Hermel M, Prenner J, Alabdulrazzak M, Dailey W, Hartzer M.
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar 03; 247(3):331-4. PubMed ID: 19034484
    [Abstract] [Full Text] [Related]

  • 18. Elevated levels of proteolytic enzymes in the aging human vitreous.
    Vaughan-Thomas A, Gilbert SJ, Duance VC.
    Invest Ophthalmol Vis Sci; 2000 Oct 03; 41(11):3299-304. PubMed ID: 11006217
    [Abstract] [Full Text] [Related]

  • 19. Correlation of the extent and duration of rhegmatogenous retinal detachment with the expression of matrix metalloproteinases in the vitreous.
    Symeonidis C, Diza E, Papakonstantinou E, Souliou E, Dimitrakos SA, Karakiulakis G.
    Retina; 2007 Oct 03; 27(9):1279-85. PubMed ID: 18046238
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.